(Check
One): ý Form
10-K ¨ Form
20-F ¨ Form
11-K ¨ Form
10-Q ¨ Form
10-D ¨ Form
N-SAR ¨ Form
N-CSR
For
Period Ended: March
31,
2008
¨ Transition Report
on Form 10-K
¨ Transition Report
on Form 20-F
¨ Transition Report
on Form 11-K
¨ Transition Report
on Form 10-Q
¨ Transition Report
on Form N-SAR
For
the Transition Period
Ended: ____________________________________________________
|
Immtech Pharmaceuticals, Inc. |
Full Name of Registrant |
Former Name if Applicable |
One North End Avenue |
Address of Principal Executive Office (Street and Number) |
New York, NY 10282 |
City, State and Zip Code |
(a)
|
The
reason described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense
|
|
ý
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report or transition report on Form
10-Q, or portion thereof, will be filed on or before the fifth calendar
day following the prescribed due date; and
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
Eric
L. Sorkin
|
212
|
791-2911
|
||
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If answer
is no, identify report(s). ýYes ¨No
|
(3)
|
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof? x
Yes ¨No
|
Immtech Pharmaceuticals,
Inc.
|
(Name
of Registrant as Specified in Charter)
|
has
caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
|
Date: June
17, 2008
|
By:
|
/s/ Eric L. Sorkin |
Eric
L. Sorkin
Chief
Executive Officer and President
|